Date of Award
1-1-2001
Thesis Type
Masters
Document Type
Thesis
Divisions
Faculty of Science
Department
Department of Chemistry
Institution
Universiti Malaya
Abstract
A non-aqueous titration method was developed to assay Loratadine bulk active and a High Performance Liquid Chromatography (HPLC) method was developed to determine Loratadine's manufacturing impurity. The HPLC method was also suitable for simultaneously assay and related substance determination of Loratadine pharmaceutical preparations. In the tritation method, glacial acetic acid was chosen as an amphiprotic solvent. Loratadine ionised in glacial acetic acid; the conjugated base of acetic acid (Ac·), was then titrated with standardised perchloric acid. The method was validated found to be precise, linear and robust. Reverse-phase HPLC method using a Novapak Cl8 column with a CH3CN: I0mM K2HPO4 (pH 7.7) (50:50 v/v) mobile phase, showed good separation of Loratadine and its degradation products. The method was validated and performed satisfactorily with respect to specificity, precision, accuracy, linearity, robustness and ruggedness. The quantitation limit was 0.1 µg/mL with a RSD of 7.9% and the detection limit was 0.02 µg/mL with a RSD of 10.7% with six consecutive injections of 20µL injection volume. The described methods have been demonstrated to be useful for the determination of Loratadine assay and its degradation products or manufacturing impurities in the active raw material and pharmaceutical preparations.
Additional Information
Dissertation (M.A) -- Faculty of Science, Universiti Malaya, 2001.
Recommended Citation
Puen, Kian Yong, "Analysis of loratadine by potentiometry and reverse-phase high performance liquid chromatography" (2001). Student Works (2000-2009). 558.
https://knova.um.edu.my/student_works_2000s/558
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Included in
Analytical Chemistry Commons, Pharmaceutical Preparations Commons, Pharmaceutics and Drug Design Commons
Initial
snms